WO2025238416 - INDOLE DERIVATIVES, USES AND COMPOSITIONS THEREOF
National phase entry is expected:
Publication Number
WO/2025/238416
Publication Date
20.11.2025
International Application No.
PCT/IB2025/000216
International Filing Date
16.05.2025
Title **
[English]
INDOLE DERIVATIVES, USES AND COMPOSITIONS THEREOF
[French]
DÉRIVÉS D'INDOLE, UTILISATIONS ET COMPOSITIONS ASSOCIÉES
Applicants **
MINDSET PHARMA INC.
Inventors
SLASSI, Abdelmalik
ARAUJO, Joseph, A.
Priority Data
63/648,405
16.05.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CIPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 8587 | |
| EPO | Filing, Examination, Granting | 260225 | |
| Japan | Filing, Examination, Granting | 5571 | |
| South Korea | Filing, Examination, Granting | 15276 | |
| USA | Filing, Examination, Granting | 91640 |
Total:
381,299
Contact Us
Abstract[English]
The present application relates to derivatives of psilocybin of general Formula (I), to processes for their preparation, to compositions comprising them and to their use in activation of a serotonin receptor in a cell, as well as to treating diseases, disorders or conditions by activation of a serotonin receptor in a cell. For example, the methods of treating diseases, disorders or conditions by activation of a serotonin receptor in a cell. The diseases, disorders or conditions include, for example, psychosis, mental illnesses, and other neurological diseases, disorders and conditions.[French]
La présente invention concerne des dérivés de psilocybine de formule générale (I), des procédés pour leur préparation, des compositions les comprenant et leur utilisation dans l'activation d'un récepteur de la sérotonine dans une cellule, ainsi que pour le traitement de maladies, de troubles ou d'affections par activation d'un récepteur de la sérotonine dans une cellule. L'invention concerne, par exemple, les méthodes de traitement de maladies, de troubles ou d'affections par activation d'un récepteur de la sérotonine dans une cellule. Parmi les maladies, troubles ou affections figurent, par exemple, la psychose, les maladies mentales et d'autres maladies, troubles et affections neurologiques.